Vanguard Group
PMI

Vanguard Group’s Picard Medical PMI Stock Holding History

Vanguard Group’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$49.3K Buy
+28,145
New +$132K ﹤0.01% 4250

Other funds holding PMI

AC
Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AHL
Abel Hall LLC Baton Rouge, Louisiana $469M AUM 34.1% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group's PMI Position: Q4 2025 in Review

Vanguard Group opened a new position in Picard Medical (PMI) in Q4 2025: 28,145 shares worth $49.3K. The stake represents ﹤0.01% of the portfolio and ranks #4250 among its holdings.

31 funds tracked by Wall St. Rank hold PMI as of Q4 2025.

  • Vanguard Group held 28,145 shares of Picard Medical worth $49.3K as of Q4 2025.
  • Picard Medical was a new Vanguard Group position in Q4 2025.
  • Picard Medical made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4250 holding.
  • 31 funds tracked by Wall St. Rank held Picard Medical as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.